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Abstract
Perfluorooctane sulfonate (PFOS) poses potential risks to reproduction and development. Mouse embryonic stem cells
(mESCs) are ideal models for developmental toxicity testing of environmental contaminants in vitro. However, the
mechanism by which PFOS affects early embryonic development is still unclear. In this study, mESCs were exposed to PFOS
for 24 h, and then general cytotoxicity and pluripotency were evaluated. MTT assay showed that neither PFOS (0.2 mM,
2 mM, 20 mM, and 200 mM) nor control medium (0.1% DMSO) treatments affected cell viability. Furthermore, there were no
significant differences in cell cycle and apoptosis between the PFOS treatment and control groups. However, we found that
the mRNA and protein levels of pluripotency markers (Sox2, Nanog) in mESCs were significantly decreased following
exposure to PFOS for 24 h, while there were no significant changes in the mRNA and protein levels of Oct4. Accordingly, the
expression levels of miR-145 and miR-490-3p, which can regulate Sox2 and Nanog expressions were significantly increased.
Chrm2, the host gene of miR-490-3p, was positively associated with miR-490-3p expression after PFOS exposure. Dual
luciferase reporter assay suggests that miR-490-3p directly targets Nanog. These results suggest that PFOS can disturb the
expression of pluripotency factors in mESCs, while miR-145 and miR-490-3p play key roles in modulating this effect.
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Introduction
Perfluorooctane sulfonate (PFOS) has been widely used as a
surface-active agent for a wide range of commercial, industrial and
household applications, including water repellents, lubricants,
paints, and fire-fighting foams [1]. It has been identified in various
environmental sectors, including air [2], sewage sludge [3,4],
snow, lake, and surface runoff water [5]. PFOS is also commonly
detected in maternal serum, amniotic fluid [6], umbilical cord
blood [7], breast milk [8], nail, hair and urine [9] and semen [10].
PFOS is a kind of persistent lipophilic compound which exhibited
high degrees of bioconcentration from water and biomagnification
from food [11,12]. As it has been shown to bind strongly to plasma
albumin [13], there is a high accumulation of PFOS in humans, so
it has a long half-life in serum (5.4 y) [14]. In light of its
environmental persistence, bioaccumulation, and potential toxic-
ity, PFOS exposure generates great concern about its potential
impacts on health. There is a large body of evidence to support
potential adverse effects of PFOS on development in humans and
animals. Epidemiology studies have found that exposure to PFOS
is correlated with reduced birth weight [15,16], motor or mental
developmental milestones in early childhood [17]. Even in non-
human primates, PFOS exposure has been shown to cause
decreased body weights [18]. In addition, PFOS exposure can
induce neonatal death [19,20,21], delayed growth and develop-
ment, and delayed eye opening in rodents [20,22,23]. In aquatic
models, such as zebrafish and medaka, PFOS-induced abnormal-
ities have been observed. Exposure to PFOS could alter
immunoregulation functions in fish larvae, impact F1 offspring
morphology, behavior, and survival in zebrafish [24,25], and
result in a decrease in hatch time and hatch rate [26,27]. Although
numerous studies have suggested the developmental toxicity of
PFOS, little is known about the underlying molecular mecha-
nisms.
Mouse embryonic stem cells (mESCs), derived from inner cell
mass of preimplantation blastocysts, while propagating in pluri-
potency state, maintain the capacity to generate any cell type in
the body. As the existing toxicity assays using fully differentiated
cell lines or immortal cell lines can’t reflect a series of stages during
the embryonic development, mESCs may be an ideal model for
in vitro testing safety or toxicity of chemicals and environmental
contaminants. Elucidation of the transcriptional regulatory
circuitry operating in ES cells is fundamental for understanding
the molecular mechanisms of pluripotency.
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Many studies have demonstrated that microRNAs (miRNAs)
played important roles in development. Mice without miRNAs die
at embryonic day 7.5 [28]. miRNAs are required for the formation
of many tissues, such as the vertebrate limb [29], skin [30], and the
lung epithelium [31]. miRNAs are also important components of
the transcriptional regulatory networks and these have emerged as
central players in the maintenance of ESC self-renewal and
differentiation [32,33,34]. They may offer a mean to direct the
differentiation of ES cells into desired fates and inhibit the
formation of undesired lineages, such as the cardiac differentiation
[35], and neural differentiation [36].
In this study, to better understand the effects and the molecular
mechanisms of PFOS on early embryonic development, we tested
the effects of PFOS on general cytotoxicity and pluripotency of
mESCs, and further explored the role of miRNAs in PFOS-
induced effects.
Materials and Methods
Chemicals and Reagents
PFOS ($98% purity), dimethyl sulfoxide (DMSO), bovine
serum albumin (BSA), diethylpyrocarbonate (DEPC), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
were obtained from Sigma-Aldrich (St. Louis, MO, USA). Stock
solution of PFOS was dissolved in DMSO at a concentration of
200 mM, stored at 220uC, and then diluted to desired
concentrations in culture medium immediately before use. The
final concentration of DMSO in the culture medium did not
exceed 0.1%. All chemicals were of analytical grade.
Cell Culture and PFOS Treatment
Mouse ES cell line D3 [American Type Culture Collection
(ATCC), Manassas, VA, USA, no.CRL-11632] was kindly
provided by Stem Cell Bank, Chinese Academy of Sciences. This
cell line has been widely used in previous studies [37,38]. mESCs
were grown on mouse embryonic fibroblast feeder cells (MEF) that
were treated by mitomycin C in knock-out Dulbecco’s modified
Eagle’s medium (Gibco BRL, Grand Island, NY) supplemented
with 20% ES qualified fetal bovine serum (Gibco BRL), 0.1 mM
b-mercaptoethanol (Sigma Chemical, St Louis, MO), 0.1 mM
nonessential amino acids (Gibco BRL), 0.1 mM L-glutamine
(Gibco BRL), 0.1 mM pyruvate sodium, 100 unit/ml penicillin/
streptomycin (Gibco BRL) and 1000 U/ml of leukemia inhibitory
factor (LIF) (Millipore, Billerica, MA). Fresh medium was changed
every day, and cells were passaged every 3 days at 37uC and 5%
CO2. Cells were dislodged using trypsin/EDTA (Gibco BRL).
Before the start of experiments, feeder cells were depleted by
incubating trypsinized cells in complete ES cells medium on cell
culture dishes for 30 min, during which time feeder cells attached
to the dish while mESCs not. The mESCs were treated with PFOS
(0.2 mM, 2 mM, 20 mM, and 200 mM) dissolved in DMSO. Cells
were exposed to 0.1% DMSO as a negative control.
Human 293T cells were obtained from ATCC (Manassas VA,
USA) and cultured in complete growth medium DMEM (Hyclone,
UT, USA), supplemented with 10% fetal bovine serum (10%
FBS), 100 U/mL penicillin, and 100 mg/mL streptomycin at
37uC, 5% CO2.
Cell Viability Assay, Morphological Study and Alkaline
Phosphatase Staining
The feeder depleted ES cells were seeded on gelatin coated
plates at a density of about 1.56104 per well in 96-well plates and
16106 per well in 6-well plates and incubated overnight. ES
cellular viability was evaluated using the MTT proliferation assay.
MTT (5 mg/ml) was dissolved in PBS, sterilized by filtration
through a 0.22 mm MilliporeH filter and stored at 4uC. After
exposure to PFOS at different concentrations, the cells were
washed twice with PBS. Then 25 ml of MTT were added to each
well, and the cells were incubated for 4 h at 37uC to allow MTT
metabolism. The medium was replaced with 150 ml DMSO, plates
were shaken for 10 min, and the absorbance was determined at
490 nm. Results were presented as percentage of the control.
The morphology of cells was examined and recorded using
phase contrast microscope (Olympus, CK41, Japan) after exposure
to PFOS (0.2 mM, 2 mM, 20 mM, and 200 mM) or control
medium (0.1% DMSO). Alkaline phosphatase (AP) staining was
performed with the Alkaline Phosphatase Complete Kit (Sidansai
Corporation of Biotechnology, Shanghai, China) according to the
manufacturer’s protocol. The cells were washed twice with PBS
and fixed for 2 min with fixing solution at room temperature. The
cells were washed with PBS and incubated with AP staining
solution for 30 min, protected from light. After being washed with
PBS, the cells were photographed using a microscope (Olympus,
CK41, Japan).
Cell Cycle Analysis and Apoptosis Assay
To determine if PFOS could affect the cell cycle and induce
apoptosis of mESCs, flow cytometric analysis was used to
determine the state of cell cycle and apoptosis. Feeder depleted
ES cells were seeded on gelatin-coated 6-well plates at a density of
about 16106 cells per well. Cells were incubated overnight and
subsequently exposed to PFOS (0.2 mM, 2 mM, 20 mM, and
200 mM) and 0.1% DMSO. After 24 h, cells were washed with
PBS and harvested with trypsin/EDTA. Cells were fixed in 75%
ethanol for 2 h or washed in cold PBS, then stained with
propidium iodide (PI) and annexin V for 30 min protected from
light. The fixed/stained cells were analyzed by FACS Calibur
Flow Cytometry (BD Biosciences, NJ, USA) to quantify cell cycle
or cell apoptosis.
RNA Isolation and Quantitative Real-Time PCR Assay
Total RNA was isolated using TRIZOL reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions, and
the concentration of total RNA was determined by measuring the
absorbance at 260 nm. cDNA synthesis for coding genes and
miRNAs were performed with 1 mg of total RNA according the
manufacturer’s instructions (Takara, Tokyo, Japan).
mRNA (Oct4, Sox2, Nanog, Chrm2, GAPDH) and miRNAs
The expression of miRNAs (has/mmu-miR-145, has/mmu-miR-
490-3p, U6) were analyzed using SYBR PCR Master Mix reagent
kits (Takara) according to the manufacturer’s instructions. Primer
sequences are shown in Table S1. All oligonucleotide primers were
synthesized by Invitrogen (Shanghai). All real-time PCR reactions
were carried out on ABI7900 Fast Real-Time System (Applied Bio
systems, Foster City, CA, USA) according to the manufacturer’s
instructions. All experiments were repeated at least three times.
Western Blot Analysis
The total cellular proteins were extracted using radio immuno-
precipitation assay (RIPA) buffer containing protease inhibitors
(Complete, Roche, Basel, Switzerland). Protein concentrations
were determined using bicinchoninic acid (BCA) Protein Assay kit
(Biyuntian, China). Equal amounts of protein (60 mg) from each
sample that solubilized in the sample buffer (25 mM Tris, pH 6.8,
1% SDS (w/v), 5% b-mercaptoethanol(v/v), 1 mM EDTA, 4%
glycerol, and 0.01% bromophenol blue) were fractionated by
PFOS Exposure on Mouse Embryonic Stem Cells
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electrophoresis on a 12.3% polyacrylamide-SDS gel at 90 V for
3 h. The proteins were then transferred to a polyvinyldiene
difluoride membrane (PVDF, Bio-Rad, Hercules, CA). The
membrane with transferred proteins was incubated in buffer
containing specific rabbit polyclonal antibodies for Sox2/Nanog
or goat polyclonal antibodies for Oct4 (Abcam, Kendall square,
MA, USA, 1:1000 dilution), followed by incubating with goat anti-
rabbit or donkey anti-goat secondary antibody conjugated with
horseradish peroxidase at 1:1000. The specific signals were
detected by the enhanced chemiluminescence (ECL Western
blotting detection reagents, Amersham Life Science Limited). The
amount of GAPDH (34 kDa) in each lane was used as a loading
control for the amount of Oct4 (45 kDa), Sox2 (43 kDa), or Nanog
(35 kDa). All experiments were repeated at least three times. Blots
were quantified by densitometry and normalized by the use of
GAPDH to correct for differences in loading of the proteins. For
densitometric analyses, the bands on the blots were measured by
Eagle Eye II Still Video Imaging System (Stratagene, La Jolla,
CA).
Bioinformatics: Predict Potential miRNAs, mRNA
miR-145 has been previously identified as targeting Sox2 in
hESC [39]. We filtered the microRNA.org and identified miR-
490-3p as targeting Nanog. Cholinergic muscarinic receptor 2
(Chrm2), as the host gene of miR-490-3p, was identified by
miRBase [40].
Transfection and Dual-luciferase Reporter Gene Assay
Synthetic miRNA precursor molecules of miR-490-3p, a
negative control, miR-490-3p inhibitor and a inhibitor control
(GenePharma, Shanghai, China) were used in transfection
experiments. Human 293T cells were cultured to about 50%
confluence and transfection was carried out using Lipofectamine
2000 (Invitrogen Corp, CA, USA) with 50 nM miR-490-3p
mimics, a negative control,100 nM miR-490-3p inhibitor or a
inhibitor control in 6-well plates respectively. After 24 h of
transfection, total RNA was isolated from the transfected cells.
The 39UTR sequence of Nanog predicted to interact with miR-
490-3p or a mutated sequence with the predicted target sites were
inserted into the KpnI and SacI sites of pGL3 promoter vector
(Genscript, Nanjing, China). These constructs were named pGL3-
Nanog-miR 490-3p-WT, pGL3-Nanog-miR 490-3p-Mut. For
reporter gene assay, cells were plated onto 24-well plates and
transfected with 800 ng of the pGL3- Nanog-miR-490-3p-WT,
pGL3-Nanog-miR-490-3p-Mut, 50 nM miR-490-3p mimics and
control respectively. A Renilla luciferase vector pRL-SV40 (5 ng)
was also co-transfected to normalize the differences in transfection
efficiency. Cells were collected at 24 h posttransfection and
luciferase assays were performed with a dual-luciferase reporter
system (Promega, Madison, WI) according to the manufacturer’s
instructions. Firefly luciferase activity measured was normalized to
Renilla luciferase activity. Transfection was repeated three times
in triplicate.
Data Analysis
Statistical analysis was performed using STATA9.2 (Stata
CorpStata Corp, LP). Values are expressed as means 6S.E. for
all experiments. Statistically significant differences between the
treatments and the control were examined by one-way ANOVA,
followed by Dunnett’s multiple comparison test. We used the
method of 22DDCt to analyze the results of RT-PCR. All tests of
statistical significance were two-sided, and the statistical signifi-
cance was set at p,0.05.
Results
Effects of PFOS on Cell Viability, Morphology and Alkaline
Phosphatase Staining in mESCs
To identify the effects of PFOS on cell viability and
morphology, D3 mESCs were exposed to various concentrations
of PFOS for 24 h and 48 h. As shown in Figure 1A, 1B. PFOS
treatment significantly affected cell viability at 300 mM and
400 mM doses. After 24 h of treatment with PFOS, the
morphology of mESCs was similar to that of control cells treated
with DMSO (Figure 1C). To determine whether PFOS influences
pluripotency, we stained mESCs with alkaline phosphatase (AP).
We observed that mESCs treated with PFOS for 24 h did not
appear differentiated and were similar to the control cells with
deep staining and full colony morphology (Figure 1D). Since there
is no difference in cytotoxic effects between 24 h treatment and
48 h treatment, in all of the following experiments, cells were
exposed to PFOS for 24 h.
Effects of PFOS on Cell Cycle and Apoptosis in mESCs
We examined the effects of PFOS on the cell cycle and
apoptosis after 24 h exposure by flow cytometery. We found no
significant difference in cell cycle between treatment groups and
the control group (Figure S1A and S1B), nor were there any
significant difference in apoptosis between treatment groups and
the control group (Figure S1C and S1D).
Effects of PFOS on the Potential and the Relative
Expression of miR-145 and miR-490-3p in mESCs
We detected the effects of PFOS on the potential by examining
the expression of self-renewal factors (Oct4, Sox2, Nanog).
Exposure to PFOS in mESCs significantly decreased expression
of Sox2, Nanog, at both mRNA and protein levels. However, the
mRNA and protein levels of Oct4 were unchanged (Figure 2A,
Figure 2B).
To explore the mechanisms by which PFOS disturbed the
observed altered expression of Sox2, Nanog in mESCs, the
expressions of miR-145 and miR-490-3p which may target Sox2,
Nanog were evaluated. We found that both miR-145 and miR-490-
3p were dose dependently increased after PFOS exposure.
The Expression Chrm2 after PFOS Exposure
We compared the expression levels of miR-490-3p host gene
Chrm2 after PFOS exposure by qRT-PCR (Figure 3A). The
expressions of Chrm2 were increased. In order to explore a
potential relationship between miR-490-3p and Chrm2, the
Pearson correlation analysis was performed. A significantly
positive correlation was found between the expression levels of
miR-490-3p and Chrm2 (R2= 0.7902, p,0.001. Figure S2),
indicating that miR-490-3p was transcribed together with its host
gene Chrm2.
Transfection and Dual-luciferase Reporter Gene Assays
We predicted miR-490-3p might be the potential miRNA for
targeting Nanog mRNA, and our results showed an increase of
miR-490-3p and a corresponding decrease of Nanog expression
after PFOS exposure, To further validate the hypothesis that miR-
490-3p regulates Nanog expression after PFOS exposure, we
transfected miR-490-3p mimics and a negative control precursor,
miR-490-3p inhibitor and a inhibitor control precursor in 293T
cells. The mRNA and protein levels of Nanog were evaluated after
transfection for 24 h. As expected, qRT-PCR analysis showed that
the relative expression levels of Nanog mRNA was decreased with
PFOS Exposure on Mouse Embryonic Stem Cells
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miR-490-3p mimics and Nanog mRNA was increased with miR-
490-3p inhibitor in 293T cells (Figure 3B). To confirm the
efficiency of transfection assay, the miRNA expression level of
miR-490-3p was measured after transfection with miR-490-3p
mimics and a negative control precursor, miR-490-3p inhibitor and
a inhibitor control precursor. The results showed that the relative
expression levels of miR-490-3p were increased with miR-490-3p
mimics and that of miR-490-3p expression levels were decreased
with miR-490-3p inhibitor in 293T cells (Figure 3C).
To investigate whether miR-490-3p directly bind to the 39UTR
regions of Nanog, we performed miRNA dual luciferase reporter
assay by constructing the wild type and mutant type luciferase
reporter plasmids containing the binding region of the 39UTR of
Nanog mRNA. We found that co-transfection of miR-490-3p
mimics and pGL3-Nanog 39UTR reporter plasmids significantly
decreased the luciferase activity in 293T cells, as compared with
the control (Figure 3D, Figure 3E). These results suggested that
miR-490-3p could directly target Nanog.
Discussion
Previous reports have shown that PFOS was associated with
developmental toxicity. In this study, we analyzed the effects of
PFOS exposure on pluripotency of mESCs. Results showed that
PFOS exposure didn’t cause any changes in morphology and AP
staining of mESCs, but resulted in downregulation of pluripotency
markers (Sox2, Nanog) expression both at the mRNA and protein
levels, which agreed with the fact that EtOH, 17b-Estradiol, 4-
tert-octylphenol (OP) and 4-nonylphenol (NP), did not change AP
activity in mESCs, but affected the expression of some pluripo-
tency factors [41,42].
Nanog, the natural killer-2 class homeobox transcription factor,
can control a cascade of pathways, including pluripotency, self-
renewal, genome surveillance and cell fate determination [43].
Nanog can also sustain pluripotency in ES cells even in the
absence of LIF [44]. Knockdown of Nanog can induce differen-
tiation to extraembryonic endoderm and trophectoderm lineages
in Human ESCs [45]. Nanog deficient mESCs lose pluripotency
and differentiate into extraembryonic endoderm lineage [46].
Sox2, the SRY family member, can promote the expression of
ESC-specific genes and suppress differentiation in the transcrip-
tional network [47]. It is indispensable for maintaining ESC
pluripotency. Sox2-null ES cells can differentiate primarily into
trophoectoderm-like cells [48]. Collectively, both Sox2 and Nanog
are essential in the maintenance of ESC self-renewal and
pluripotency. The expression level of Nanog was decreased after
exposure to 0.2 mM PFOS in mESCs, and 0.2 mM can represent
occupational exposure to PFOS [49]. Moreover, it is reported that
Figure 1. Effects of PFOS on cell viability and morphology in mESCs. (A and B) Cell viability was determined by MTT assay after exposure to
various concentrations of PFOS for 24 h and 48 h. (C) D3 mESCs was exposed to PFOS for 24 h, cell morphology was observed. Magnification, 1006.
Cells were cultured with various concentrations of PFOS (0.2 mM, 2 mM, 20 mM, and 200 mM) or DMSO as control. (D) Effects of PFOS on alkaline
phosphatase staining in mESCs. Cells were cultured with various concentrations of PFOS (0.2 mM, 2 mM, 20 mM, and 200 mM) or DMSO as control.
Scale bar = 25 mm. Values of the experiment were represented as the percentages of cell viability compared with that of the control and expressed as
means 6 S.E. from five separate experiments in which treatments were performed in quadruplicate. *indicates significant difference when the values
were compared to that of the control at p,0.05.
doi:10.1371/journal.pone.0074968.g001
PFOS Exposure on Mouse Embryonic Stem Cells
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exposure to PFOS(1027 M) is correlated with motor or mental
developmental milestones in early childhood in humans [17].
Similarly, the expression level of Sox2 was decreased at 2 mM, and
2 mM is aquatic environmentally relevant. There is also a report
indicating that PFOS(1026 M) exposure can induce toxicity in
zebrafish [50]. Therefore, the biological significance of our
findings regarding the effect of low-dose PFOS on the expression
of Sox2, Nanog should be taken into consideration.
The discovery of miRNAs provides an new layer for gene
regulation, and miRNAs are thought to be functionally important
in regulating the self-renewal and pluripotency of ESCs [51,52].
Previous studies indicate that miRNAs control the expression of
pluripotency factors [53,54]. By using bioinformatic software
(microRNA.org), we predicted that miR-490-3p might be the
potential miRNA for targeting Nanog mRNA. By combing the
results obtained from transfection and dual luciferase reporter
assay, we firstly confirmed that miR-490-3p regulated the
expression of Nanog in mESCs, which provided a new insight
into PFOS-induced toxicity in mESCs. miR-145 had been
previously identified as targeting Sox2 in hESCs [39]. As miR-
145 is homologous miRNA in both of human and mouse, so it
may also play an important role in modulating mESCs pluripo-
tency through its ability to target and regulate the expression of
Sox2 in mESCs.
While cytoxicity was observerd in Vero cells [55], neonatal
gonocyte and Sertoli cells [56], ESCs-derived cardiomyocytes
[57], Neural stem cells [58], Cerebellar granule cells [59], human
adrenocortical carcinoma [60] after PFOS exposure (,100 mM),
Figure 2. Effects of PFOS on pluripotency and expressions of miR-145, miR-490-3p in mESCs. Cells were cultured with various
concentrations of PFOS (0.2 mM, 2 mM, 20 mM, and 200 mM) or DMSO as control for 24 h. (A) Oct-4/Sox-2/Nanog mRNA levels were determined by
quantitative real-time PCR using a housekeeping gene GAPDH as an internal control. (B) The protein levels of Oct-4/Sox-2/Nanog were determined by
Western blot analysis using GAPDH as an internal control. (C) miRNA levels(miR-145, miR-490-3p) were determined by quantitative real-time PCR and
were normalized to U6 as an internal control. Each data point was normalized to the control (DMSO) and represented the means 6 S.E. from three
independent experiments. (D) Relative protein levels of Oct4, Sox2 and Nanog. *indicates significant difference when the values were compared to
that of the control (p,0.05).
doi:10.1371/journal.pone.0074968.g002
PFOS Exposure on Mouse Embryonic Stem Cells
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the morphology and AP staining of mESCs were unchanged up to
200 mM of PFOS. However, as we mentioned above, the
expression level of Nanog was decreased at 0.2 mM and the
expression level of Sox2 was decreased at 2 mM. Therefore, at
relatively low doses, although PFOS didn’t alter the phenotype of
mESCs, the gene alterations have occurred, which may be due to
unlimited proliferation and high self-renewal of mESCs.
Conclusions
The current study revealed that PFOS exposure could decrease
the expression of Nanog and Sox2 in mESCs. In addition, our
findings showed that miR-490-3p could directly target Nanog.
Meanwhile, results here also suggested that PFOS could affect the
expression of Chrm2, which might, at least in part, modulate miR-
490-3p expression. These findings allow us to conclude that miR-
490-3p and its host gene Chrm2 regulate Nanog expression in
Figure 3. Over-expression of miR-490-3p reduced Nanog expression. (A)The expression of its host gene Chrm2 mRNA levels was determined
by quantitative real-time PCR using a housekeeping gene GAPDH as an internal control. Cells were cultured with various concentrations of PFOS
(0.2 mM, 2 mM, 20 mM, and 200 mM) or DMSO as control for 24 h. (B) Cells were transfected with 50 nM miR-490 mimics or 100 nM miR-490 inhibitor
for 24 h. qRT-PCR was performed to evaluate the mRNA level of Nanog. (C) The relative expression levels of miR-490-3p after transfection. (D) Cells
were co-transfected with miR-490-3p mimics and negative control, renilla luciferase vector pRL-SV40 and Nanog 39UTR luciferase reporters for 24 h.
Both firefly and Renilla luciferase activities are measured in the same sample. Firefly luciferase signals were normalized with Renilla luciferase signals.
(E) Sequence alignment of miR-490-3p with 39 UTR of Nanog. Bottom: mutations in the 39UTR of Nanog in order to create the mutant luciferase
reporter constructs. *indicates significant difference compared with that of control cells (P,0.05). All tests were performed in triplicate and presented
as means6SE. Reporter activity was significantly decreased after miR-490-3p overexpression compared to control (P,0.05).
doi:10.1371/journal.pone.0074968.g003
PFOS Exposure on Mouse Embryonic Stem Cells
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mESCs, providing novel insights into the molecular mechanisms
of developmental toxicity of PFOS.
Supporting Information
Figure S1 Effects of PFOS on cell cycle and apoptosis in
mESC. Cells were cultured with various concentrations of PFOS
(0.2 mM, 2 mM, 20 mM, and 100 mM) or DMSO as control for
24 h. The cell cycle and apoptosis were analyzed by flow
cytometry. 10,000 cells were analyzed for each sample. (A and
B) The pictures of cell cycle were shown in (A). Data of the
experiment was expressed as a percentage of total cells. Results
quantitated in cell cycle were shown in (B). (C and D) Cells in the
LL quadrant indicated that they were live cells. Cells in the LR
quadrant were in the early stages of apoptosis. Cells in the UR
quadrant were late apoptotic (C). The percentage of apoptotic cells
was also presented in histogram (D). Each data point was
represented as the means 6 S.E. from three separate experiments
in which treatments were performed in triplicate.
(TIF)
Figure S2 Correlation between the levels of miR-490-3p
and Chrm2 by Pearson correlation analysis. (R2 = 0.7902,
p,0.001).
(TIF)
Table S1 Sequences of primers for qRT-PCR.
(DOCX)
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